PolyActiva's PA5346 Ocular Implant Trial for Glaucoma Underway
A clinical study is evaluating the efficacy, safety, and biodegradation of the PA5346 Ocular Implant in patients with open-angle glaucoma or ocular hypertension.
Asset / Drug
Drug and asset intelligence for Glaucoma Underway with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.